General Information of the Compound
Compound ID
CP0561832
Compound Name
4-[2-(pyrazolo[3,4-c]pyridin-1-ylmethyl)benzimidazol-1-yl]butan-1-ol
    Show/Hide
Structure
Formula
C18H19N5O
Molecular Weight
321.384
Canonical SMILES
OCCCCn1c(Cn2ncc3ccncc23)nc2ccccc12
    Show/Hide
InChI
InChI=1S/C18H19N5O/c24-10-4-3-9-22-16-6-2-1-5-15(16)21-18(22)13-23-17-12-19-8-7-14(17)11-20-23/h1-2,5-8,11-12,24H,3-4,9-10,13H2
    Show/Hide
InChIKey
UYEQJFQWWCIWTD-UHFFFAOYSA-N
Physicochemical Property
logP
2.6018
Rotatable Bonds
6
Heavy Atom Count
24
Polar Areas
68.76
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
6
Complexity
24

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 145955112
ChEMBL ID
CHEMBL4170167
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00459, Fusion glycoprotein F0
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000668 HEp-2 Homo sapiens (Human)  1
1
EC50 = 2200 nM
   TI
   LI
   LO
   TS